Cameron Watt - 1933 INDUSTRIES Executive Vice President

TGIFF -- USA Stock  

USD 0.20  0.0041  2.01%

  President
Mr. Cameron Watt is Executive Vice President, Director of the Company. Mr. Watt combines over 30 years of successful business negotiation and strategic leadership experience in various industries, with a talent for developing, launching and managing businesses. A business graduate of the British Columbia Institute of Technology, Mr. Watt focuses on the execution of deliverables, and has played a significant role in the transition of several organizations experiencing rapid growth in highly competitive markets.
  President Since 2018      
604-674-4756  http://www.1933Industries.com

Management Efficiency

The company has return on total asset (ROA) of (10.43) % which means that it has lost $10.43 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (38.9) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 9.04 M in total debt with debt to equity ratio (D/E) of 23.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. 1933 INDUSTRIES INC has Current Ratio of 4.88 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Dominique BrardIPSEN
2014
Satoru YasudaEISAI CO
2016
Aimin HuiSHANGHAI FOSUN PHARMACEUTICAL G
2017
Jean FabreIPSEN
2013
Changzheng MaSHANGHAI FOSUN PHARMACEUTICAL G
2013
Xiaojun DingSHANGHAI FOSUN PHARMACEUTICAL G
2012
Aris GennadiosCatalent
2013
Dongjiu LiSHANGHAI FOSUN PHARMACEUTICAL G
2012
Masayuki MiyajimaEISAI CO
2016
Robert StewartAllergan Plc
N/A
Jonathon KellermanAllergan Plc
2014
Ivana MagovcevicIPSEN
2018
Scott HoultonCatalent
2015
Jingping MeiSHANGHAI FOSUN PHARMACEUTICAL G
2019
Paul NavarreAllergan Plc
John SheehanMylan NV
N/A
Rakesh BamzaiMylan NV
2014
Yi LiuSHANGHAI FOSUN PHARMACEUTICAL G
2017
Cheng WangSHANGHAI FOSUN PHARMACEUTICAL G
2012
Jiayu ShiSHANGHAI FOSUN PHARMACEUTICAL G
N/A
Jianglin HuSHANGHAI FOSUN PHARMACEUTICAL G
2012

Entity Summary

1933 Industries Inc., a cannabis company, engages in the cultivation and production of medical marijuana in the United States and Canada. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. was incorporated in 2008 and is headquartered in Chilliwack, Canada. Friday Night operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on OTC Market. It employs 70 people.1933 INDUSTRIES INC [TGIFF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

1933 INDUSTRIES INC Leadership Team

George Tsafalas, Director
Andrew Richards, Director
Andy Richards, Director
David Stadnyk, Director
Brian Farrell, Director
Joseph Campo, Interim CFO, Director
Christopher Wolfenberg, Corporate Secretary, Director
Chris Rebentisch, Director
Cameron Watt, Executive Vice President
Melanie Blair, Independent Director
David Lane, Interim CEO, Director

Stock Performance Indicators

Current Sentiment - TGIFF

1933 INDUSTRIES INC Investor Sentiment

Macroaxis portfolio users are evenly split in their outlook on investing in 1933 INDUSTRIES INC. What is your sentiment towards investing in 1933 INDUSTRIES INC? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Currently Active Assets on Macroaxis

REI-UN   
Purchased over 100 shares of
few hours ago
Traded for 24.76
OTEX   
Purchased over 200 shares of
few hours ago
Traded for 53.38
KXS   
Purchased over 60 shares of
few hours ago
Traded for 78.1
IFC   
Purchased over 40 shares of
few hours ago
Traded for 97.23
GDI   
Purchased over 100 shares of
few hours ago
Traded for 29.6
Also please take a look at World Market Map. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Search macroaxis.com